Clínica Universidad de Navarra (CUN)
Centro clínico de la Universidad de Navarra
Duke University
Durham, Estados UnidosPublicaciones en colaboración con investigadores/as de Duke University (28)
2024
-
2023 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting
ESMO Open, Vol. 9, Núm. 2
-
A road map for the treatment of pediatric diffuse midline glioma
Cancer Cell
-
Long-term efficacy and safety of subcutaneous tocilizumab in clinical trials of polyarticular or systemic juvenile idiopathic arthritis
Rheumatology (United Kingdom), Vol. 63, Núm. 9, pp. 2535-2546
2022
-
COVID-19 pandemic impact on cytopathology practice in the post-lockdown period: An international, multicenter study
Cancer Cytopathology, Vol. 130, Núm. 5, pp. 344-351
-
Recirculating hyperthermic intravesical chemotherapy with mitomycin C (HIVEC) versus BCG in high-risk non-muscle-invasive bladder cancer: results of the HIVEC-HR randomized clinical trial
World Journal of Urology, Vol. 40, Núm. 4, pp. 999-1004
2021
-
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
Autophagy, Vol. 17, Núm. 1, pp. 1-382
-
Isatuximab as monotherapy and combined with dexamethasone in patients with relapsed/refractory multiple myeloma
Blood, Vol. 137, Núm. 9, pp. 1154-1165
2020
-
A dose-finding Phase 2 study of single agent isatuximab (anti-CD38 mAb) in relapsed/refractory multiple myeloma
Leukemia, Vol. 34, Núm. 12, pp. 3298-3309
-
Global impact of the COVID-19 pandemic on cytopathology practice: Results from an international survey of laboratories in 23 countries
Cancer Cytopathology, Vol. 128, Núm. 12, pp. 885-894
-
Sarcoma treatment in the era of molecular medicine
EMBO Molecular Medicine, Vol. 12, Núm. 11
2019
-
B cell-adaptive immune profile in emphysema-predominant chronic obstructive pulmonary disease
American Journal of Respiratory and Critical Care Medicine
2016
-
Consensus guidelines on plasma cell myeloma minimal residual disease analysis and reporting
Cytometry Part B - Clinical Cytometry, Vol. 90, Núm. 1, pp. 31-39
-
Immunomodulatory activity of nivolumab in metastatic renal cell carcinoma
Clinical Cancer Research
-
International Myeloma Working Group Recommendations for the Diagnosis and Management of Myeloma-Related Renal Impairment
Journal of Clinical Oncology, Vol. 34, Núm. 13, pp. 1544-1557
-
Therapeutic impact of cytoreductive surgery and irradiation of posterior fossa ependymoma in the molecular era: A retrospective multicohort analysis
Journal of Clinical Oncology, Vol. 34, Núm. 21, pp. 2468-2477
2015
-
Intraoperative Irradiation
Clinical Radiation Oncology (Elsevier Inc.), pp. 325-340.e3
-
Recurrent venous thromboembolism in anticoagulated patients with cancer: Management and short-term prognosis
Journal of Thrombosis and Haemostasis, Vol. 13, Núm. 6, pp. 1010-1018
2011
-
Conclusions and Future Possibilities: IORT
INTRAOPERATIVE IRRADIATION: TECHNIQUES AND RESULTS, SECOND EDITION
-
IORT with Electron-Beam, High-Dose-Rate Brachytherapy or Low-KV/Electronic Brachytherapy: Methodological Comparisons
INTRAOPERATIVE IRRADIATION: TECHNIQUES AND RESULTS, SECOND EDITION (HUMANA PRESS INC), pp. 99-115
-
Intraoperative Electron Beam Irradiation: Physics and Techniques
INTRAOPERATIVE IRRADIATION: TECHNIQUES AND RESULTS, SECOND EDITION (HUMANA PRESS INC), pp. 51-72